CAPRICOR THERAPEUTICS
Capricor Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of cell and exosome-based therapeutics for the treatment and prevention of diseases. Its CAP-1002 is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and COVID-19. The company was founded in 2005 and is headquartered in Los Angeles, California.
CAPRICOR THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2005-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.capricor.com
Total Employee:
11+
Status:
Active
Contact:
(310) 358-3200
Email Addresses:
[email protected]
Total Funding:
66.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Sitelinks Search Box
Similar Organizations
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Nucleonics
Nucleonics is a biotechnology company focused on RNA interference-based therapeutics.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Capricor Therapeutics
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Capricor Therapeutics
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Capricor Therapeutics
Cedars Sinai
Cedars Sinai investment in Post-IPO Equity - Capricor Therapeutics
CureDuchenne Ventures
CureDuchenne Ventures investment in Post-IPO Equity - Capricor Therapeutics
Broadview Ventures
Broadview Ventures investment in Post-IPO Equity - Capricor Therapeutics
Calmedica
Calmedica investment in Post-IPO Equity - Capricor Therapeutics
Beechwood Ventures
Beechwood Ventures investment in Post-IPO Equity - Capricor Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-02 | Capricor Therapeutics Names Dr. Daniel Paulson as Vice President of Clinical Development |
Official Site Inspections
http://www.capricor.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.98 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
